QDEL:NASDAQ
Quidelortho Corp
$10.38
arrow_downward
-1.52%(-0.16) 1D
$10.49
arrow_upward
+1.09% (+0.11)todayPre-market
Closed: Oct 1, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$10.55
High
$10.64
Low
$9.93
Mkt. cap
711.81M
Avg. vol.
1.37M
Volume
7.00
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.68
Shares outstanding
68.58M
No. of employees
6K
Open
$10.55
High
$10.64
Low
$9.93
Mkt. cap
711.81M
Avg. vol.
1.37M
Volume
7.00
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.68
Shares outstanding
68.58M
No. of employees
6K
News stories
From web sources and news partners
Barron's
·
10 minutes ago
S&P 500 Futures Climb in Premarket Trading; Seagate Technology, Nike Lag
24/7 Wall St.
·
7 minutes ago
IWM Has Trailed the S&P 500 for a Decade While Carrying More Risk: The Small-Cap Premium That Never Fully Arrived
TipRanks
·
3 minutes ago
Warner Bros. Is Set to Leave Nasdaq 100 and S&P 500 Indexes after $81 Billion Paramount Buyout
Investor's Business Daily
·
1 hour ago
Twilio To Join S&P 500 Index
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorMedical device
Websitequidelortho.com